ZIMBABWE has introduced Cabotegravir long-acting (CAB-LA), an injectable pre-exposure prophylaxis drug, to add to the HIV prevention regime in the country. Read More
Reading Time: < 1 minuteFunding for HIV responses in low- and middle-income countries fell by $2.1 billion (£1.6bn) last year after the Trump administration made substantial…